NICHOLAS BARTHELEMY Insider Trading $RGEN REPLIGEN CORP
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for NICHOLAS BARTHELEMY.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of NICHOLAS BARTHELEMY. NICHOLAS BARTHELEMY is Director in REPLIGEN CORP ($RGEN) and Director in FLUIDIGM CORP ($FLDM) and Director in 908 Devices Inc. ($MASS) and in Twist Bioscience Corp ($TWST) and Director in Twist Bioscience Corp ($TWST).
NICHOLAS BARTHELEMY in REPLIGEN CORP
Trading Symbol: RGENIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of NICHOLAS BARTHELEMY: Director
Holdings: 5,673 shares
Current Value: $165,879
Latest Transaction: May 26 2020
$RGEN Market Capitalization: $984.14M
$RGEN Previous Close: $29.24
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of NICHOLAS BARTHELEMY in REPLIGEN CORP
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, MASS, FLDM, RGEN, TWST
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 26 2020 | RGEN | REPLIGEN CORP | BARTHELEMY NICOLAS | Director | Option Exercise | M | 67.71 | 2,109 | 142,800 | 0 | |
May 26 2020 | RGEN | REPLIGEN CORP | BARTHELEMY NICOLAS | Director | Sell | S | 142.53 | 3,009 | 428,873 | 2,664 | 5.7 K to 2.7 K (-53.04 %) |
May 26 2020 | RGEN | REPLIGEN CORP | BARTHELEMY NICOLAS | Director | Buy | M | 67.71 | 2,109 | 142,800 | 5,673 | 3.6 K to 5.7 K (+59.18 %) |
May 19 2020 | RGEN | REPLIGEN CORP | BARTHELEMY NICOLAS | Director | Option Exercise | A | 128.18 | 1,285 | 164,711 | 1,285 | |
May 19 2020 | RGEN | REPLIGEN CORP | BARTHELEMY NICOLAS | Director | Grant | A | 0.00 | 527 | 0 | 3,564 | 3 K to 3.6 K (+17.35 %) |
Apr 24 2020 | RGEN | REPLIGEN CORP | BARTHELEMY NICOLAS | Director | Option Exercise | M | 42.07 | 1,652 | 69,500 | 0 | |
Apr 24 2020 | RGEN | REPLIGEN CORP | BARTHELEMY NICOLAS | Director | Sell | S | 109.99 | 2,688 | 295,653 | 3,037 | 5.7 K to 3 K (-46.95 %) |
Apr 24 2020 | RGEN | REPLIGEN CORP | BARTHELEMY NICOLAS | Director | Buy | M | 42.07 | 1,652 | 69,500 | 5,725 | 4.1 K to 5.7 K (+40.56 %) |
Apr 06 2020 | RGEN | REPLIGEN CORP | BARTHELEMY NICOLAS | Director | Option Exercise | M | 42.07 | 1,652 | 69,500 | 1,652 | |
Apr 06 2020 | RGEN | REPLIGEN CORP | BARTHELEMY NICOLAS | Director | Sell | S | 99.99 | 2,688 | 268,773 | 4,073 | 6.8 K to 4.1 K (-39.76 %) |
Apr 06 2020 | RGEN | REPLIGEN CORP | BARTHELEMY NICOLAS | Director | Buy | M | 42.07 | 1,652 | 69,500 | 6,761 | 5.1 K to 6.8 K (+32.34 %) |
May 17 2019 | RGEN | REPLIGEN CORP | BARTHELEMY NICOLAS | Director | Option Exercise | A | 67.71 | 2,109 | 142,800 | 2,109 | |
May 17 2019 | RGEN | REPLIGEN CORP | BARTHELEMY NICOLAS | Director | Grant | A | 0.00 | 923 | 0 | 5,109 | 4.2 K to 5.1 K (+22.05 %) |
Aug 31 2018 | RGEN | REPLIGEN CORP | BARTHELEMY NICOLAS | Director | Option Exercise | M | 41.19 | 1,992 | 82,050 | 0 | |
Aug 31 2018 | RGEN | REPLIGEN CORP | BARTHELEMY NICOLAS | Director | Option Exercise | M | 38.76 | 2,434 | 94,342 | 0 | |
Aug 31 2018 | RGEN | REPLIGEN CORP | BARTHELEMY NICOLAS | Director | Sell | S | 54.44 | 6,580 | 358,196 | 4,186 | 10.8 K to 4.2 K (-61.12 %) |
Aug 31 2018 | RGEN | REPLIGEN CORP | BARTHELEMY NICOLAS | Director | Buy | M | 41.19 | 1,992 | 82,050 | 10,766 | 8.8 K to 10.8 K (+22.70 %) |
Aug 31 2018 | RGEN | REPLIGEN CORP | BARTHELEMY NICOLAS | Director | Buy | M | 38.76 | 2,434 | 94,342 | 8,774 | 6.3 K to 8.8 K (+38.39 %) |
May 17 2018 | RGEN | REPLIGEN CORP | BARTHELEMY NICOLAS | Director | Option Exercise | A | 42.07 | 3,304 | 138,999 | 3,304 | |
May 17 2018 | RGEN | REPLIGEN CORP | BARTHELEMY NICOLAS | Director | Grant | A | 0.00 | 1,486 | 0 | 6,340 | 4.9 K to 6.3 K (+30.61 %) |
May 11 2018 | RGEN | REPLIGEN CORP | BARTHELEMY NICOLAS | Director | Option Exercise | M | 26.12 | 3,366 | 87,920 | 0 | |
May 11 2018 | RGEN | REPLIGEN CORP | BARTHELEMY NICOLAS | Director | Option Exercise | M | 20.37 | 24,000 | 488,880 | 0 | |
May 11 2018 | RGEN | REPLIGEN CORP | BARTHELEMY NICOLAS | Director | Sell | S | 40.54 | 26,500 | 1,074,238 | 4,854 | 31.4 K to 4.9 K (-84.52 %) |
May 11 2018 | RGEN | REPLIGEN CORP | BARTHELEMY NICOLAS | Director | Buy | M | 26.12 | 3,366 | 87,920 | 31,354 | 28 K to 31.4 K (+12.03 %) |
May 11 2018 | RGEN | REPLIGEN CORP | BARTHELEMY NICOLAS | Director | Buy | M | 20.37 | 24,000 | 488,880 | 27,988 | 4 K to 28 K (+601.81 %) |
May 22 2017 | RGEN | REPLIGEN CORP | BARTHELEMY NICOLAS | Director | Option Exercise | A | 38.76 | 2,434 | 94,342 | 2,434 | |
May 22 2017 | RGEN | REPLIGEN CORP | BARTHELEMY NICOLAS | Director | Grant | A | 0.00 | 1,206 | 0 | 3,988 | 2.8 K to 4 K (+43.35 %) |
May 13 2016 | RGEN | REPLIGEN CORP | BARTHELEMY NICOLAS | Director | Option Exercise | A | 26.12 | 3,366 | 87,920 | 3,366 | |
May 13 2016 | RGEN | REPLIGEN CORP | BARTHELEMY NICOLAS | Director | Grant | A | 0.00 | 1,763 | 0 | 2,782 | 1 K to 2.8 K (+173.01 %) |
May 26 2015 | RGEN | REPLIGEN CORP | BARTHELEMY NICOLAS | Director | Option Exercise | A | 41.19 | 1,992 | 82,050 | 1,992 | |
May 26 2015 | RGEN | REPLIGEN CORP | BARTHELEMY NICOLAS | Director | Grant | A | 0.00 | 1,019 | 0 | 1,019 | 0 to 1 K |
Page: 1